Jayson Rieger

2.5k total citations
47 papers, 2.1k citations indexed

About

Jayson Rieger is a scholar working on Physiology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Jayson Rieger has authored 47 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Physiology, 11 papers in Molecular Biology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Jayson Rieger's work include Adenosine and Purinergic Signaling (25 papers), Mechanical Circulatory Support Devices (7 papers) and Spinal Cord Injury Research (6 papers). Jayson Rieger is often cited by papers focused on Adenosine and Purinergic Signaling (25 papers), Mechanical Circulatory Support Devices (7 papers) and Spinal Cord Injury Research (6 papers). Jayson Rieger collaborates with scholars based in United States, Australia and United Kingdom. Jayson Rieger's co-authors include Joel Linden, Timothy L. Macdonald, Courtney M. Lappas, Gail W. Sullivan, Milton L. Brown, Mark D. Okusa, John A. Kern, W. Michael Scheld, Robert A. Figler and Liping Huang and has published in prestigious journals such as Circulation, Journal of Neuroscience and Blood.

In The Last Decade

Jayson Rieger

46 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jayson Rieger United States 27 1.2k 531 393 330 301 47 2.1k
Juan C. Ibla United States 21 1.1k 0.9× 590 1.1× 374 1.0× 174 0.5× 128 0.4× 65 2.4k
Joel Linden United States 21 778 0.7× 648 1.2× 385 1.0× 138 0.4× 245 0.8× 29 1.8k
Anna Lisa Giuliani Italy 27 1.8k 1.5× 1.0k 1.9× 677 1.7× 326 1.0× 132 0.4× 70 3.5k
Balázs Csóka United States 29 1.8k 1.5× 807 1.5× 886 2.3× 470 1.4× 201 0.7× 39 3.0k
Hitoshi Harada Japan 29 994 0.8× 640 1.2× 266 0.7× 221 0.7× 91 0.3× 114 2.2k
Alba Clara Sarti Italy 23 1.8k 1.6× 1.2k 2.2× 707 1.8× 341 1.0× 144 0.5× 27 3.3k
Hong Ye United States 23 360 0.3× 1.0k 2.0× 835 2.1× 482 1.5× 105 0.3× 39 2.6k
Amanda B. Mackenzie United Kingdom 16 1.0k 0.8× 851 1.6× 498 1.3× 166 0.5× 122 0.4× 22 2.0k
Linda Yip United States 17 1.0k 0.9× 565 1.1× 578 1.5× 150 0.5× 67 0.2× 36 1.9k
Monique Freund France 32 649 0.5× 692 1.3× 314 0.8× 54 0.2× 115 0.4× 68 3.3k

Countries citing papers authored by Jayson Rieger

Since Specialization
Citations

This map shows the geographic impact of Jayson Rieger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jayson Rieger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jayson Rieger more than expected).

Fields of papers citing papers by Jayson Rieger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jayson Rieger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jayson Rieger. The network helps show where Jayson Rieger may publish in the future.

Co-authorship network of co-authors of Jayson Rieger

This figure shows the co-authorship network connecting the top 25 collaborators of Jayson Rieger. A scholar is included among the top collaborators of Jayson Rieger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jayson Rieger. Jayson Rieger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Rutman, Howard, Mark L. McBride, Eric Grigsby, et al.. (2024). EFFICACY OF XT-150, A NOVEL NON-VIRAL GENE THERAPY DELIVERING IL-10v, ON MODERATE TO SEVERE PAIN DUE TO KNEE OSTEOARTHRITIS: PATIENT SUBGROUP ANALYSIS. Osteoarthritis and Cartilage. 32. S41–S41. 5 indexed citations
3.
Eichenfield, Lawrence F., Elaine C. Siegfried, Pearl Kwong, et al.. (2021). Pooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum Contagiosum. American Journal of Clinical Dermatology. 22(2). 257–265. 9 indexed citations
4.
Guenthner, Scott, Jayson Rieger, David K. Glover, et al.. (2021). Phase II, Double-Blind, Vehicle-Controlled Study to Determine the Cantharidin Dose Regimen, Efficacy, Safety, and Tolerability of VP-102 in Subjects with External Genital Warts. American Journal of Clinical Dermatology. 22(6). 867–875. 1 indexed citations
5.
Grigsby, Eric, Dominic Thewlis, L Simon, et al.. (2021). XT-150- A novel immunomodulatory gene therapy for osteoarthritis pain in phase 2b development. Osteoarthritis and Cartilage. 29. S12–S12. 9 indexed citations
6.
Kwilasz, Andrew J., Amanda Ellis, Lewis O. Harvey, et al.. (2018). A single peri-sciatic nerve administration of the adenosine 2A receptor agonist ATL313 produces long-lasting anti-allodynia and anti-inflammatory effects in male rats. Brain Behavior and Immunity. 76. 116–125. 16 indexed citations
7.
Voloshyna, Iryna, Steven E. Carsons, Michael J. Littlefield, et al.. (2012). Adenosine A2A receptor activation supports an atheroprotective cholesterol balance in human macrophages and endothelial cells. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1831(2). 407–416. 20 indexed citations
8.
Doyle, Susan E., et al.. (2012). Time and sex-dependent effects of an adenosine A2A/A1 receptor antagonist on motivation to self-administer cocaine in rats. Pharmacology Biochemistry and Behavior. 102(2). 257–263. 22 indexed citations
9.
Warren, Cirle A., Gina M. Calabrese, Yuesheng Li, et al.. (2012). Effects of adenosine A2A receptor activation and alanyl-glutamine in Clostridium difficile toxin-induced ileitis in rabbits and cecitis in mice. BMC Infectious Diseases. 12(1). 13–13. 26 indexed citations
10.
Loram, Lisa C., Jacqueline A. Harrison, Evan M. Sloane, et al.. (2009). Enduring Reversal of Neuropathic Pain by a Single Intrathecal Injection of Adenosine 2A Receptor Agonists: A Novel Therapy for Neuropathic Pain. Journal of Neuroscience. 29(44). 14015–14025. 86 indexed citations
11.
Wilson, Jeffrey M., William G. Ross, Oma N. Agbai, et al.. (2009). The A2B Adenosine Receptor Impairs the Maturation and Immunogenicity of Dendritic Cells. The Journal of Immunology. 182(8). 4616–4623. 113 indexed citations
12.
Lappas, Courtney M., Jayson Rieger, & Joel Linden. (2005). A2A Adenosine Receptor Induction Inhibits IFN-γ Production in Murine CD4+ T Cells. The Journal of Immunology. 174(2). 1073–1080. 320 indexed citations
13.
Day, Yuan‐Ji, Yuesheng Li, Jayson Rieger, et al.. (2005). A2A Adenosine Receptors on Bone Marrow-Derived Cells Protect Liver from Ischemia-Reperfusion Injury. The Journal of Immunology. 174(8). 5040–5046. 84 indexed citations
14.
Kong, Yali, Jolanta Grembecka, Michael Edler, et al.. (2005). Structure-Based Discovery of a Boronic Acid Bioisostere of Combretastatin A-4. Chemistry & Biology. 12(9). 1007–1014. 67 indexed citations
15.
Riou, Laurent, Mirta Ruiz, Jayson Rieger, et al.. (2002). Influence of propranolol, enalaprilat, verapamil, and caffeine on adenosine A2A-receptor–mediated coronary vasodilation. Journal of the American College of Cardiology. 40(9). 1687–1694. 18 indexed citations
16.
Cassada, David C., Curtis G. Tribble, Jeffrey S. Young, et al.. (2002). Adenosine A2A Analogue Improves Neurologic Outcome after Spinal Cord Trauma in the Rabbit. The Journal of Trauma: Injury, Infection, and Critical Care. 53(2). 225–231. 32 indexed citations
17.
Cassada, David C., Curtis G. Tribble, Stewart M. Long, et al.. (2002). Adenosine A2A agonist reduces paralysis after spinal cord ischemia: correlation with A2A receptor expression on motor neurons. The Annals of Thoracic Surgery. 74(3). 846–850. 41 indexed citations
18.
Murphree, Lauren J., Melissa A. Marshall, Jayson Rieger, Timothy L. Macdonald, & Joel Linden. (2002). Human A2AAdenosine Receptors: High-Affinity Agonist Binding to Receptor-G Protein Complexes Containing Gβ4. Molecular Pharmacology. 61(2). 455–462. 78 indexed citations
19.
Sullivan, Gail W., Jayson Rieger, W. Michael Scheld, Timothy L. Macdonald, & Joel Linden. (2001). Cyclic AMP‐dependent inhibition of human neutrophil oxidative activity by substituted 2‐propynylcyclohexyl adenosine A2A receptor agonists. British Journal of Pharmacology. 132(5). 1017–1026. 145 indexed citations
20.
Brown, Milton L., Jayson Rieger, & Timothy L. Macdonald. (2000). Comparative molecular field analysis of colchicine inhibition and tubulin polymerization for combretastatins binding to the colchicine binding site on β-tubulin. Bioorganic & Medicinal Chemistry. 8(6). 1433–1441. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026